云顶换帅+觅瑞拿证:背后这家“非常规”资本,孵化控股模型进入出海验证阶段

MedTrend医趋势
Oct 10, 2025

一免费参会,扫码报名一10月的医药圈,两个热点事件看似无关,却指向同一个关键玩家。一边是云顶新耀官宣人事震动:掌舵多年的傅唯卸任董事会主席,转任非执行董事;接棒者是前一天刚加入康桥资本的吴以芳,这位有35年行业经验的“老将”,曾把复星医药的创新药销售额占比拉升20个百分点。扩展阅读:云顶新耀宣布重磅人事:原复星医药董事长吴以芳加盟并出任董事会主席另一边是Mirxes觅瑞的“觅小卫®”拿下NMPA...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10